[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@bio_report Avatar @bio_report BioReport

BioReport posts on X about $mygn, $srpt, $capr, stocks the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXXX% cryptocurrencies XXXXX% stocks XXXXX% technology brands XXXXX%

Social topic influence $mygn #4, $srpt #39, $capr #36, stocks 11.11%, $lmt 11.11%, $meta 11.11%, $czr 11.11%, meta 11.11%, $exas 11.11%, $gh XXXXX%

Top accounts mentioned or mentioned by @martinshkreli @venu7 @anthonystaj

Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Limitus (LMT) Metadium (META) Caesars Entertainment, Inc. (CZR) Exact Sciences Corp (EXAS) Guardant Health, Inc. Common Stock (GH) Club Atletico Independiente Fan Token (CAI)

Top Social Posts

Top posts by engagements in the last XX hours

"$MYGN if shares are really down on competing prostate cancer test then youre not following the stock closely. Revenue for that test is immaterial"
X Link 2025-12-01T19:01Z 1236 followers, XXX engagements

"Stocks way undervalued; - $MYGN -$LMT -$META -$SRPT -$CAPR -$CZR"
X Link 2025-12-02T15:44Z 1236 followers, XXX engagements

"Pretty shocking that $MYGN does not trade with an acquisition premium. Its the only buyable company with any significant hereditary cancer business in a space all the big somatic players want to enter. Its also one of the few money making diagnostic tests $CAI $EXAS $GH"
X Link 2025-11-11T15:31Z 1235 followers, XXX engagements

"Maybe $CAPR should buy $SRPT"
X Link 2025-12-03T15:45Z 1236 followers, 1292 engagements